{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:20:38Z","timestamp":1792243238696,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Skin of Color Society"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016492","name":"Kiniksa Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jaad.2020.04.182","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T01:38:24Z","timestamp":1590284304000},"page":"1567-1575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":183,"title":["Prurigo nodularis"],"prefix":"10.1016","volume":"83","author":[{"given":"Kyle A.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah","family":"Belzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn G.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.04.182_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMe1916733","article-title":"Breaking the itch\u2013scratch cycle in prurigo nodularis","volume":"382","author":"Kwatra","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.182_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2133.2011.10306.x","article-title":"Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy","volume":"165","author":"Schuhknecht","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib3","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2174\/0929867043364748","article-title":"Tachykinins and tachykinin receptors: structure and activity relationships","volume":"11","author":"Almeida","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jaad.2020.04.182_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.det.2018.02.003","article-title":"Prurigo nodularis and its management","volume":"36","author":"Zeidler","year":"2018","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2020.04.182_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00105-014-2754-y","article-title":"Pathogenese der prurigo nodularis","volume":"65","author":"Raap","year":"2014","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaad.2020.04.182_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s004030000142","article-title":"Eosinophil cationic protein- and eosinophil-derived neurotoxin\/eosinophil protein X-immunoreactive eosinophils in prurigo nodularis","volume":"292","author":"Johansson","year":"2000","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2020.04.182_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1440-0960.2005.00187.x","article-title":"Prurigo nodularis: a review","volume":"46","author":"Lee","year":"2005","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0560.1998.tb01718.x","article-title":"Histamine-containing mast cells and their relationship to NGFr-immunoreactive nerves in prurigo nodularis: a reappraisal","volume":"25","author":"Liang","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2020.04.182_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.182_bib10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaad.2020.04.182_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0625.2008.00766.x","article-title":"Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC\/Nga mice: a model of atopic dermatitis","volume":"18","author":"Grimstad","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib12","first-page":"897","article-title":"Le n\u00e9vrome de la lich\u00e9nification circonscrite nodulaire chronique (lichen ruber obtusus corn\u00e9, prurigo nodularis)","volume":"41","author":"Pautrier","year":"1934","journal-title":"Ann Dermatol Syphil"},{"key":"10.1016\/j.jaad.2020.04.182_bib13","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/exd.13343","article-title":"There is no functional small-fibre neuropathy in prurigo nodularis despite\u00a0neuroanatomical alterations","volume":"26","author":"Pereira","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib14","first-page":"4","article-title":"Association between prurigo nodularis and etiologies of peripheral neuropathy: suggesting a role for neural dysregulation in pathogenesis","volume":"7","author":"Hughes","year":"2020","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.jaad.2020.04.182_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jdermsci.2010.03.020","article-title":"Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis","volume":"58","author":"Haas","year":"2010","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2020.04.182_bib16","first-page":"97","article-title":"Diagnostic workup and evaluation of patients with prurigo nodularis","volume":"6","author":"Kwon","year":"2019","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.jaad.2020.04.182_bib17","first-page":"221","article-title":"Prurigo nodularis: picking the right treatment","volume":"64","author":"Saco","year":"2015","journal-title":"J Fam Pract"},{"key":"10.1016\/j.jaad.2020.04.182_bib18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2019.07.022","article-title":"Diagnostic and treatment algorithm for chronic nodular prurigo","volume":"82","author":"St\u00e4nder","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.det.2018.02.002","article-title":"Diagnostic work-up of the itchy patient","volume":"36","author":"Elmariah","year":"2018","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2020.04.182_bib20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1600-0560.2009.01484.x","article-title":"Prurigo nodularis: systematic analysis of 58 histological criteria in 136 patients","volume":"37","author":"Weigelt","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2020.04.182_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaad.2019.09.007","article-title":"Analysis of real-world treatment patterns in patients with prurigo nodularis","volume":"82","author":"Huang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2340\/00015555-2774","article-title":"Chronic prurigo of nodular type: a review","volume":"98","author":"Zeidler","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2020.04.182_bib23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/09546630903386606","article-title":"An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis","volume":"21","author":"Saraceno","year":"2010","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2020.04.182_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000355671","article-title":"Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone- controlled, double-blind phase II trial","volume":"227","author":"Siepmann","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2020.04.182_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1067\/mjd.2001.110059","article-title":"Treatment of prurigo nodularis with topical capsaicin","volume":"44","author":"St\u00e4nder","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1468-3083.2010.03865.x","article-title":"UVB 308-nm excimer light and bath PUVA: combination therapy is very effective in the treatment of prurigo nodularis","volume":"25","author":"Hammes","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2020.04.182_bib27","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.jaad.2014.09.050","article-title":"Successful use of a\u00a0modified Goeckerman regimen in the treatment of generalized prurigo nodularis","volume":"72","author":"Sorenson","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/09546634.2013.814759","article-title":"Prurigo nodularis: an update on etiopathogenesis and therapy","volume":"24","author":"Fostini","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2020.04.182_bib29","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/13543784.2018.1548606","article-title":"Novel drugs for the treatment of chronic pruritus","volume":"27","author":"Pereira","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaad.2020.04.182_bib30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/ced.12365","article-title":"Prurigo nodularis: retrospective study of 13 cases managed with methotrexate","volume":"39","author":"Spring","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/jdv.14646","article-title":"Treatment of prurigo with methotrexate: a multicentre retrospective study of 39 cases","volume":"32","author":"Klejtman","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2020.04.182_bib32","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1610-0387.2008.06745.x","article-title":"Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: results of a case series [in German]","volume":"6","author":"Siepmann","year":"2008","journal-title":"JDDG"},{"key":"10.1016\/j.jaad.2020.04.182_bib33","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaad.2018.02.024","article-title":"Rapid improvement of prurigo nodularis with cyclosporine treatment","volume":"78","author":"Wiznia","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaad.2016.02.1237","article-title":"Gabapentin and pregabalin for the treatment of chronic pruritus","volume":"75","author":"Matsuda","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib35","doi-asserted-by":"crossref","first-page":"4790810","DOI":"10.1155\/2017\/4790810","article-title":"Aprepitant for the treatment of chronic refractory pruritus","volume":"2017","author":"He","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jaad.2020.04.182_bib36","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jaad.2019.01.052","article-title":"Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial","volume":"80","author":"St\u00e4nder","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib37","doi-asserted-by":"crossref","first-page":"e10968","DOI":"10.1371\/journal.pone.0010968","article-title":"Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy","volume":"5","author":"St\u00e4nder","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2020.04.182_bib38","author":"Terry"},{"key":"10.1016\/j.jaad.2020.04.182_bib39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaad.2015.09.039","article-title":"Thalidomide for the treatment of chronic refractory pruritus","volume":"74","author":"Sharma","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2340\/00015555-0997","article-title":"Efficacy of thalidomide in the treatment of prurigo nodularis","volume":"91","author":"Taefehnorooz","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2020.04.182_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000331577","article-title":"Thalidomide in 42 patients with prurigo nodularis hyde","volume":"223","author":"Andersen","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2020.04.182_bib42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2005.12.010","article-title":"Butorphanol for treatment of intractable pruritus","volume":"54","author":"Dawn","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib43","first-page":"533","article-title":"Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases","volume":"41","author":"Metze","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5021\/ad.2016.28.2.159","article-title":"Clinical efficacy and safety of naltrexone combination therapy in older patients with severe pruritus","volume":"28","author":"Lee","year":"2016","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12882-015-0043-3","article-title":"Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus","volume":"16","author":"Hawi","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jaad.2020.04.182_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2340\/00015555-0553","article-title":"Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study","volume":"89","author":"St\u00e4nder","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2020.04.182_bib47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ajd.12996","article-title":"Prurigo successfully treated with duloxetine hydrochloride","volume":"60","author":"Hashimoto","year":"2019","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib48","first-page":"115","article-title":"Amitriptyline\/ketamine as therapy for neuropathic pruritus and pain secondary to herpes zoster","volume":"14","author":"Griffin","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib49","first-page":"433","article-title":"Amitriptyline as therapeutic and not symptomatic approach in the treatment of prurigo nodularis: a pilot study","volume":"141","author":"Zalaudek","year":"2006","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2020.04.182_bib50","article-title":"Tricyclic antidepressants for the treatment of chronic pruritus [e-pub ahead of print]","author":"Boozalis","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2020.04.182_bib51","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1606490","article-title":"Anti-interleukin-31 receptor a antibody for atopic dermatitis","volume":"376","author":"Ruzicka","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.182_bib52","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJMe1616072","article-title":"Ditching the itch with anti-type 2 cytokine therapies for atopic dermatitis","volume":"376","author":"Schneider","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.182_bib53","author":"Park"},{"key":"10.1016\/j.jaad.2020.04.182_bib54","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJMoa1908316","article-title":"Trial of nemolizumab in moderate-to-severe prurigo nodularis","volume":"382","author":"St\u00e4nder","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.182_bib55","article-title":"Cannabinoids for the treatment of chronic refractory pruritus [e-pub ahead of print]","author":"Khanna","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2020.04.182_bib56","first-page":"72","article-title":"Chronic pruritus responding to dupilumab\u2014a case series","volume":"6","author":"Zhai","year":"2019","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.jaad.2020.04.182_bib57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamadermatol.2018.3906","article-title":"Reduced itch associated with dupilumab treatment in 4 patients with prurigo nodularis","volume":"155","author":"Mollanazar","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/jamadermatol.2018.3912","article-title":"Dupilumab treatment for generalized prurigo nodularis","volume":"155","author":"Beck","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2020.04.182_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/DER.0000000000000517","article-title":"Effectiveness of dupilumab for the treatment of generalized prurigo nodularis phenotype of adult atopic dermatitis","volume":"31","author":"Napolitano","year":"2020","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaad.2020.04.182_bib60","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jdcr.2019.03.016","article-title":"Recalcitrant prurigo nodularis treated successfully with dupilumab","volume":"5","author":"Rambhia","year":"2019","journal-title":"JAAD Case Rep"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220309725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220309725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:54:39Z","timestamp":1759272879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220309725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0190962220309725"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.182","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prurigo nodularis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(20)32795-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}